• By Kristina Garcia, MGCS, CGC
  • Posted June 23, 2026

The Gene Scene: FLNC

Welcome to the Gene Scene! Each week, we will explore a gene from the ACMG Secondary Findings list—genes identified by the American College of Medical Genetics and Genomics as having clear, actionable health implications. These genes are included because they’re linked to serious but preventable or manageable conditions when identified early.…


  • By Aubrey Rose, MS, CGC
  • Posted June 16, 2026

The Gene Scene: TRDN

Welcome to the Gene Scene! Each week, we will explore a gene from the ACMG Secondary Findings list—genes identified by the American College of Medical Genetics and Genomics as having clear, actionable health implications. These genes are included because they’re linked to serious but preventable or manageable conditions when identified early.…


  • By Nina Buccafuri, MS, CGC
  • Posted June 9, 2026

The Gene Team: MSH6

Welcome to the Gene Scene! Each week, we will explore a gene from the ACMG Secondary Findings list—genes identified by the American College of Medical Genetics and Genomics as having clear, actionable health implications. These genes are included because they’re linked to serious but preventable or manageable conditions when identified early.…


  • By Amanda Jacquart, MS, LCGC
  • Posted June 2, 2026

The Gene Team: MLH3

Welcome to the Gene Scene! Each week, we will explore a gene from the ACMG Secondary Findings list—genes identified by the American College of Medical Genetics and Genomics as having clear, actionable health implications. These genes are included because they’re linked to serious but preventable or manageable conditions when identified early.…


  • By Moriah Melhado, MSPH, LCGC
  • Posted May 26, 2026

The Gene Scene: ATP7B

Welcome to the Gene Scene! Each week, we will explore a gene from the ACMG Secondary Findings list—genes identified by the American College of Medical Genetics and Genomics as having clear, actionable health implications. These genes are included because they’re linked to serious but preventable or manageable conditions when identified early.…


  • By Lauren Csukardi
  • Posted May 19, 2026

Hereditary Cancer Testing Menu Enhancements–May 2026

Our latest hereditary cancer menu enhancements are now available! Ambry is dedicated to the search for new, evidence-backed insights that can meaningfully impact patient care. Our latest findings include additional evidence for MLH3, which has resulted in an upgraded gene-disease validity (GDV) for autosomal recessive polyposis…


  • By Haley Streff, MS, CGC
  • Posted May 19, 2026

The Gene Scene: RYR2

Welcome to the Gene Scene! Each week, we will explore a gene from the ACMG Secondary Findings list—genes identified by the American College of Medical Genetics and Genomics as having clear, actionable health implications. These genes are included because they’re linked to serious but preventable or manageable conditions when identified early.…


  • By Leandros Boukas, MD, PhD
  • Posted May 13, 2026

DuoNovo: How Long-Read Sequencing Can Improve Access to Genetic Testing

Introduction:  Many of us are familiar with the classic conceptualization of genetic disorders as disorders that run in families, often illustrated in large, multi-generation pedigrees. However, the widespread application of sequencing technologies as a diagnostic tool for rare disorders has now rewritten the textbook. One of the ways it has…


  • By Jewel Wasson, MS, CGC
  • Posted May 12, 2026

The Gene Scene: SDHB

to the Gene Scene! Each week, we will explore a gene from the ACMG Secondary Findings list—genes identified by the American College of Medical Genetics and Genomics as having clear, actionable health implications. These genes are included because they’re linked to serious but preventable or manageable conditions when identified early. Here,…


  • By Connolly Steigerwald, MS, CGC
  • Posted May 5, 2026

The Gene Scene: MYBPC3

Welcome to the Gene Scene! Each week, we will explore a gene from the ACMG Secondary Findings list—genes identified by the American College of Medical Genetics and Genomics as having clear, actionable health implications. These genes are included because they’re linked to serious but preventable or manageable conditions when identified early.…